Fig. 4: The BH4 domains of Bcl-2 and Bcl-XL inhibit RyR-mediated Ca2+ release in Bcl-2 KO PACs. | Cell Death Discovery

Fig. 4: The BH4 domains of Bcl-2 and Bcl-XL inhibit RyR-mediated Ca2+ release in Bcl-2 KO PACs.

From: BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis

Fig. 4

a–c Typical traces of the Fluo-4AM single-cell Ca2+ measurements performed in Bcl-2 KO mouse PACs. At the start of each experiment cells were perfused with NaHEPES containing DMSO (vehicle). After establishing the baseline (200 s), CCK (10 pM) was added and RyR-mediated Ca2+ oscillations were measured for 5 min. Then, 50 µM of either the control peptide (a), the BH4 domain of Bcl-2 (b), or the BH4 domain of Bcl-XL (c) were added for 10 min, in the continuous presence of 10 pM CCK. d Quantification of the experiments: The area under the curve per second (AUC/sec) of the CCK-induced Ca2+ release after peptide addition (10 min recording) was compared to the AUC/sec before peptide addition (5 min recording). Each data point represents the measurement of an individual cell. The average values ± SEM are shown (P-value <0.0001). At least three independent experiments were performed per condition (N ≄ 3). For each condition at least 40 cells were recorded

Back to article page